Evidence map›Paper›PMID 36273336›Full record

ArticleMolecular biology reports2022

Interferon-gamma regulates the levels of bone formation effectors in a stage-dependent manner.

Jiumn-Horng Lai, Yu-Pao Hsu, Chin-Hua Yang, Yu-Hsu Chen, Chia-Chen Liu, Shau-Kwaun Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Interferon-JAK-STAT Axis in Bone Metabolism.Current osteoporosis reports · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Advances on T cell immunity in bone remodeling and bone regeneration.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Jiumn-Horng Lai *Department of Orthopedics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
Yu-Pao Hsu *Department of Orthopedic Surgery, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.ORCID http://orcid.org/0000-0003-3797-4514
Chin-Hua Yang *Department of Radiology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.ORCID http://orcid.org/0000-0002-4041-5126
Yu-Hsu ChenDepartment of Orthopedic Surgery, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.ORCID http://orcid.org/0000-0001-5535-9705
Chia-Chen LiuDivision of Neurology Medicine, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.ORCID http://orcid.org/0000-0002-4298-2511
Shau-Kwaun ChenInstitute of Neuroscience, National ChengChi University, No. 64, Sec. 2, Zhinan Rd., Wenshan Dist, 11605, Taipei, Taiwan, ROC. chensk@nccu.edu.tw.ORCID http://orcid.org/0000-0002-0701-6799
Ministry of Health and Welfare · TWNational Chengchi University · TWNational Tsing Hua University · TWTao Yuan General Hospital · TWTri-Service General Hospital · TW

Funding

Tao Yuan General Hospital, Ministry of Health and Welfare PTH108031Tao Yuan General Hospital, Ministry of Health and Welfare PTH108038Tao Yuan General Hospital, Ministry of Health and Welfare PTH109053Tao Yuan General Hospital, Ministry of Health and Welfare PTH109060
6 · The paper itself

Abstract

backgroundInterferon-gamma (IFN-γ) is an immune-derived cytokines in the innate and adaptive immune responses, and functions as a major pro-inflammatory cytokine. IFNγ has previously been reported involving in the regulation of bone metabolism. However, contradictory results about the roles of IFN-γ in bone formation or bone resorption have been reported. It is possible that the functions of IFN-γ in bone formation is dose-dependent or time-dependent. In this study we examined the effect of IFN-γ on different stages of osteoblastogenesis and bone formation. MATERIALS AND

methodsCell proliferation, gene expression and protein levels of the critical effectors involving in different stages of differentiation were compared between differentiating preosteoblast MC3T3-E1 treated with or without IFN-γ at different stages. Cell proliferation were determined by MTT assay. Expression levels of osteoblast differentiation markers was performed by quantitative PCR assay. Also, western blot was conducted to investigate the protein levels in those effectors.

conclusionIFN-γ regulates osteoblast and bone formation in a stage-dependent manner. IFN-γ did not alter and the expression of critical osteogenic transcription factors, such as Runx2 and Cbfb, suggesting that the differentiation was not disrupted by IFN-γ. The cell number and the levels of matrix proteins, including COL1A and BSP, at both early and late stage of osteoblastogenesis were downregulated by IFN-γ, indicating its negative regulating roles in early stages. In contrast, the mineralization protein ALP and OCN was upregulated at late stages. The results suggested that IFN-γ might act as a negative regulator in osteoblast differentiation and bone formation at early stages but switch into positive regulator at late stage. Our data revealed the complex features of the effects of IFN-γ on osteoblast differentiation. The detailed mechanisms of how IFN-γ influence on the bone formation and balance of bone remodeling will be further studied.

Indexed as

Bone ResorptionOsteogenesisBone RemodelingCell DifferentiationCore Binding Factor Alpha 1 SubunitHumansInterferon-gammaOsteoblastsCore Binding Factor Alpha 1 SubunitInterferon-gammaBone formationInterferon-gammaOsteoblastogenesis

Identifiers

PMID36273336
OpenAlexW4307101961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.